Listed

Oncolytics Biotech Inc

ONCYNasdaqCIK 1129928HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$9.4m, Q2 FY2026
Net income−$9.4m, Q2 FY2026
Line itemUnitperiod not labelled2025-03-31period not labelled2025-06-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$k2,800Research and development, period not labelled, three months to 2025-03-31$2.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001129928-26-000033.Report this figure1,916Research and development, period not labelled, three months to 2025-06-30$1.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001129928-26-000051.Report this figure4,552Research and development, Q1 FY2026, three months to 2026-03-31$4.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001129928-26-000033.Report this figure4,262Research and development, Q2 FY2026, three months to 2026-06-30$4.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001129928-26-000051.Report this figure
Operating income$k(5,021)Operating income, period not labelled, three months to 2025-03-31−$5.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001129928-26-000033.Report this figure(4,651)Operating income, period not labelled, three months to 2025-06-30−$4.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001129928-26-000051.Report this figure(9,281)Operating income, Q1 FY2026, three months to 2026-03-31−$9.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001129928-26-000033.Report this figure(9,379)Operating income, Q2 FY2026, three months to 2026-06-30−$9.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001129928-26-000051.Report this figure
Income tax$knot reported61.0Income tax, period not labelled, three months to 2025-06-30$61.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-12, accession 0001129928-26-000051.Report this figurenot reported101Income tax, Q2 FY2026, three months to 2026-06-30$101.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-12, accession 0001129928-26-000051.Report this figure
Net income$k(4,711)Net income, period not labelled, three months to 2025-03-31−$4.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001129928-26-000033.Report this figure(5,277)Net income, period not labelled, three months to 2025-06-30−$5.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001129928-26-000051.Report this figure(9,243)Net income, Q1 FY2026, three months to 2026-03-31−$9.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001129928-26-000033.Report this figure(9,442)Net income, Q2 FY2026, three months to 2026-06-30−$9.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001129928-26-000051.Report this figure
Diluted EPS$ per share(0.06)Diluted EPS, period not labelled, three months to 2025-03-31−$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001129928-26-000033.Report this figure(0.06)Diluted EPS, period not labelled, three months to 2025-06-30−$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001129928-26-000051.Report this figure(0.08)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001129928-26-000033.Report this figure(0.08)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001129928-26-000051.Report this figure
Basic EPS$ per share(0.06)Basic EPS, period not labelled, three months to 2025-03-31−$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001129928-26-000033.Report this figure(0.06)Basic EPS, period not labelled, three months to 2025-06-30−$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001129928-26-000051.Report this figure(0.08)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001129928-26-000033.Report this figure(0.08)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001129928-26-000051.Report this figure

Balance sheet

Cash and equivalents$4.1m, Q2 FY2026
Shareholders' equity−$6.2m, Q2 FY2026
Line itemUnitFY20182018-12-31FY20192019-12-31FY20202020-12-31FY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31period not labelled2025-03-31period not labelled2025-06-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m13.7Cash and equivalents, FY2018, at 2018-12-31CAD 13.7m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2022-03-03, accession 0001129928-22-000017.Report this figure14.1Cash and equivalents, FY2019, at 2019-12-31CAD 14.1m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2023-03-03, accession 0001129928-23-000008.Report this figure31.2Cash and equivalents, FY2020, at 2020-12-31CAD 31.2m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2024-03-12, accession 0001129928-24-000018.Report this figure41.3Cash and equivalents, FY2021, at 2021-12-31CAD 41.3m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2025-03-07, accession 0001129928-25-000019.Report this figure11.7Cash and equivalents, FY2022, at 2022-12-31CAD 11.7m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2025-03-07, accession 0001129928-25-000019.Report this figure34.9Cash and equivalents, FY2023, at 2023-12-31CAD 34.9m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2025-03-07, accession 0001129928-25-000019.Report this figure11.1Cash and equivalents, FY2024, at 2024-12-31$11.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-30, accession 0001129928-26-000020.Report this figurenot reportednot reported5.2Cash and equivalents, FY2025, at 2025-12-31$5.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001129928-26-000051.Report this figure5.5Cash and equivalents, Q1 FY2026, at 2026-03-31$5.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001129928-26-000033.Report this figure4.1Cash and equivalents, Q2 FY2026, at 2026-06-30$4.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001129928-26-000051.Report this figure
Current assets$m14.5Current assets, FY2018, at 2018-12-31CAD 14.5m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2020-03-06, accession 0001129928-20-000012.Report this figure18.9Current assets, FY2019, at 2019-12-31CAD 18.9m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2021-03-05, accession 0001129928-21-000013.Report this figure33.7Current assets, FY2020, at 2020-12-31CAD 33.7m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2022-03-03, accession 0001129928-22-000017.Report this figure44.9Current assets, FY2021, at 2021-12-31CAD 44.9m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2023-03-03, accession 0001129928-23-000008.Report this figure35.7Current assets, FY2022, at 2022-12-31CAD 35.7m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2024-03-12, accession 0001129928-24-000018.Report this figure38.2Current assets, FY2023, at 2023-12-31CAD 38.2m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2025-03-07, accession 0001129928-25-000019.Report this figure12.4Current assets, FY2024, at 2024-12-31$12.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-30, accession 0001129928-26-000020.Report this figurenot reportednot reported6.8Current assets, FY2025, at 2025-12-31$6.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001129928-26-000051.Report this figure7.5Current assets, Q1 FY2026, at 2026-03-31$7.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-14, accession 0001129928-26-000033.Report this figure7.1Current assets, Q2 FY2026, at 2026-06-30$7.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001129928-26-000051.Report this figure
Total assets$m14.9Total assets, FY2018, at 2018-12-31CAD 14.9m. XBRL concept ifrs-full:Assets. 20-F filed 2020-03-06, accession 0001129928-20-000012.Report this figure19.7Total assets, FY2019, at 2019-12-31CAD 19.7m. XBRL concept ifrs-full:Assets. 20-F filed 2021-03-05, accession 0001129928-21-000013.Report this figure34.3Total assets, FY2020, at 2020-12-31CAD 34.3m. XBRL concept ifrs-full:Assets. 20-F filed 2022-03-03, accession 0001129928-22-000017.Report this figure45.9Total assets, FY2021, at 2021-12-31CAD 45.9m. XBRL concept ifrs-full:Assets. 20-F filed 2023-03-03, accession 0001129928-23-000008.Report this figure37.3Total assets, FY2022, at 2022-12-31CAD 37.3m. XBRL concept ifrs-full:Assets. 20-F filed 2024-03-12, accession 0001129928-24-000018.Report this figure38.8Total assets, FY2023, at 2023-12-31CAD 38.8m. XBRL concept ifrs-full:Assets. 20-F filed 2025-03-07, accession 0001129928-25-000019.Report this figure13.4Total assets, FY2024, at 2024-12-31$13.4m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-30, accession 0001129928-26-000020.Report this figurenot reportednot reported7.6Total assets, FY2025, at 2025-12-31$7.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001129928-26-000051.Report this figure8.2Total assets, Q1 FY2026, at 2026-03-31$8.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-14, accession 0001129928-26-000033.Report this figure7.7Total assets, Q2 FY2026, at 2026-06-30$7.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001129928-26-000051.Report this figure
Current liabilities$m2.8Current liabilities, FY2018, at 2018-12-31CAD 2.8m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2020-03-06, accession 0001129928-20-000012.Report this figure12.9Current liabilities, FY2019, at 2019-12-31CAD 12.9m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2021-03-05, accession 0001129928-21-000013.Report this figure2.7Current liabilities, FY2020, at 2020-12-31CAD 2.7m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2022-03-03, accession 0001129928-22-000017.Report this figure2.7Current liabilities, FY2021, at 2021-12-31CAD 2.7m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2023-03-03, accession 0001129928-23-000008.Report this figure3.9Current liabilities, FY2022, at 2022-12-31CAD 3.9m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2024-03-12, accession 0001129928-24-000018.Report this figure4.2Current liabilities, FY2023, at 2023-12-31CAD 4.2m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2025-03-07, accession 0001129928-25-000019.Report this figure4.9Current liabilities, FY2024, at 2024-12-31$4.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-30, accession 0001129928-26-000020.Report this figurenot reportednot reported6.1Current liabilities, FY2025, at 2025-12-31$6.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001129928-26-000051.Report this figure5.4Current liabilities, Q1 FY2026, at 2026-03-31$5.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-14, accession 0001129928-26-000033.Report this figure5.2Current liabilities, Q2 FY2026, at 2026-06-30$5.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001129928-26-000051.Report this figure
Total liabilities$m8.7Total liabilities, FY2018, at 2018-12-31CAD 8.7m. XBRL concept ifrs-full:Liabilities. 20-F filed 2020-03-06, accession 0001129928-20-000012.Report this figure19.8Total liabilities, FY2019, at 2019-12-31CAD 19.8m. XBRL concept ifrs-full:Liabilities. 20-F filed 2021-03-05, accession 0001129928-21-000013.Report this figure9.6Total liabilities, FY2020, at 2020-12-31CAD 9.6m. XBRL concept ifrs-full:Liabilities. 20-F filed 2022-03-03, accession 0001129928-22-000017.Report this figure9.8Total liabilities, FY2021, at 2021-12-31CAD 9.8m. XBRL concept ifrs-full:Liabilities. 20-F filed 2023-03-03, accession 0001129928-23-000008.Report this figure10.8Total liabilities, FY2022, at 2022-12-31CAD 10.8m. XBRL concept ifrs-full:Liabilities. 20-F filed 2024-03-12, accession 0001129928-24-000018.Report this figure11.3Total liabilities, FY2023, at 2023-12-31CAD 11.3m. XBRL concept ifrs-full:Liabilities. 20-F filed 2025-03-07, accession 0001129928-25-000019.Report this figure10.1Total liabilities, FY2024, at 2024-12-31$10.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-30, accession 0001129928-26-000020.Report this figurenot reportednot reported11.4Total liabilities, FY2025, at 2025-12-31$11.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001129928-26-000051.Report this figure13.3Total liabilities, Q1 FY2026, at 2026-03-31$13.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-14, accession 0001129928-26-000033.Report this figure13.8Total liabilities, Q2 FY2026, at 2026-06-30$13.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001129928-26-000051.Report this figure
Shareholders' equity$m6.2Shareholders' equity, FY2018, at 2018-12-31CAD 6.2m. XBRL concept ifrs-full:Equity. 20-F filed 2022-03-03, accession 0001129928-22-000017.Report this figure(0.1)Shareholders' equity, FY2019, at 2019-12-31−CAD 108.0k. XBRL concept ifrs-full:Equity. 20-F filed 2023-03-03, accession 0001129928-23-000008.Report this figure24.8Shareholders' equity, FY2020, at 2020-12-31CAD 24.8m. XBRL concept ifrs-full:Equity. 20-F filed 2024-03-12, accession 0001129928-24-000018.Report this figure36.1Shareholders' equity, FY2021, at 2021-12-31CAD 36.1m. XBRL concept ifrs-full:Equity. 20-F filed 2025-03-07, accession 0001129928-25-000019.Report this figure26.5Shareholders' equity, FY2022, at 2022-12-31CAD 26.5m. XBRL concept ifrs-full:Equity. 20-F filed 2025-03-07, accession 0001129928-25-000019.Report this figure19.6Shareholders' equity, FY2023, at 2023-12-31$19.6m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-30, accession 0001129928-26-000020.Report this figure3.3Shareholders' equity, FY2024, at 2024-12-31$3.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001129928-26-000051.Report this figure3.7Shareholders' equity, period not labelled, at 2025-03-31$3.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001129928-26-000051.Report this figure3.7Shareholders' equity, period not labelled, at 2025-06-30$3.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001129928-26-000051.Report this figure(3.8)Shareholders' equity, FY2025, at 2025-12-31−$3.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001129928-26-000051.Report this figure(5.1)Shareholders' equity, Q1 FY2026, at 2026-03-31−$5.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001129928-26-000051.Report this figure(6.2)Shareholders' equity, Q2 FY2026, at 2026-06-30−$6.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001129928-26-000051.Report this figure

Cash flow

Operating cash flow−$8.1m, Q2 FY2026
Capital expenditure$0, Q2 FY2026
Line itemUnitperiod not labelled2025-03-31period not labelled2025-06-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k(4,733)Operating cash flow, period not labelled, three months to 2025-03-31−$4.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001129928-26-000033.Report this figure(4,106)Operating cash flow, period not labelled, three months to 2025-06-30−$4.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001129928-26-000051. Derived: 6-month figure less the 3-month figure.Report this figure(7,293)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$7.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001129928-26-000033.Report this figure(8,138)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$8.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001129928-26-000051. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$k1.0Capital expenditure, period not labelled, three months to 2025-03-31$1.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001129928-26-000033.Report this figure0.0Capital expenditure, period not labelled, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-12, accession 0001129928-26-000051. Derived: 6-month figure less the 3-month figure.Report this figure6.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$6.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001129928-26-000033.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-12, accession 0001129928-26-000051. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)119.74m, Q2 FY2026
Line itemUnitperiod not labelled2025-03-31period not labelled2025-06-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares84.6Diluted shares (weighted), period not labelled, three months to 2025-03-3184,631,445 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001129928-26-000033.Report this figure91.0Diluted shares (weighted), period not labelled, three months to 2025-06-3090,999,586 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001129928-26-000051.Report this figure112Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31112,292,579 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001129928-26-000033.Report this figure120Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30119,739,942 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001129928-26-000051.Report this figure

Shares outstanding: 127.51mShares outstanding, period not labelled, at 2026-08-10127,510,505 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-12, accession 0001129928-26-000051.Report this figure at Aug 10, 2026, from the cover of the 10-Q filed Aug 12, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. Listed shows no prices and gives no investment advice.